Analyst Ratings for ISIS Pharmaceuticals (ISIS) [Neutrals]

ISIS Rating Summary

ISIS Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ISIS
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $49.71 (+22%) * Over Last 12-Mos
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
10/4/2013 JPMorgan New Coverage Neutral
(N/A)
37.00
(N/A)
35.83 40.76 13.76% Details
9/4/2013 Goldman Sachs New Coverage Neutral
(N/A)
26.00
(N/A)
26.80 40.76 52.09% Details
Like ISIS Ratings? Also take a look at SNY, SAN, GSK, BIIB

ISIS Ratings News